Zepp Health (NYSE:ZEPP) PT Set at $13.87 by Fundamental Research

Zepp Health (NYSE:ZEPP) received a $13.87 price target from Fundamental Research in a research note issued on Tuesday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. Fundamental Research’s target price points to a potential upside of 351.06% from the company’s previous close.

Zepp Health Price Performance

Zepp Health stock opened at $3.08 on Tuesday. Zepp Health has a 52 week low of $2.06 and a 52 week high of $4.38. The firm has a market cap of $46.28 million, a P/E ratio of -1.23 and a beta of 0.75. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.87 and a current ratio of 1.21. The business’s fifty day moving average is $2.98 and its two-hundred day moving average is $3.09.

Institutional Investors Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Mandatum Life Insurance Co Ltd purchased a new stake in shares of Zepp Health Co. (NYSE:ZEPP) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,750 shares of the company’s stock, valued at approximately $28,000. Mandatum Life Insurance Co Ltd owned about 0.07% of Zepp Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.